Every compound, with the data behind it

5-AMINO-1MQ

This is a Certified Reference Material (CRM) comprising high-purity 5-Amino-1MQ (5-amino-1-methylquinolinium). Unlike peptide-based incretins, this is a Small Molecule Inhibitor targeting the cytosolic enzyme Nicotinamide N-methyltransferase (NNMT). It is engineered strictly for Cellular Metabolic Profiling, focusing on cellular bioenergetics, NAD+ flux quantification, and satellite cell proliferation in myofiber models. Molecular Identity: Chemical Name : 5-amino-1-methylquinolinium iodide CAS Number : 42464-96-0 (Iodide Salt) Target : NNMT Enzyme (Cytosolic) Mechanism : NAD+ Salvage Pathway Modulation

Adipotide FTPP

Adipotide is a synthetic chimeric peptidomimetic studied in preclinical research models for its targeted interaction with white-adipose-tissue vasculature. Its structure combines the CKGGRAKDC homing domain with the D(KLAKLAK)₂ proapoptotic effector domain. PubChem lists Adipotide under CID 163360068, while RUO catalogues commonly reference the acetate salt under CAS 859216-15-2. For research use only. Not approved for human use.

AMY-Cg

AMY-Cg (AM-833; CAS 1393461-38-5) is a synthetic, lipidated long-acting analogue of the pancreatic peptide hormone amylin, engineered for sustained activity at all three amylin receptor subtypes (AMY1R, AMY2R, AMY3R) and the calcitonin receptor (CTR) — classifying it as a dual amylin and calcitonin receptor agonist (DACRA). A C20 fatty diacid N-terminal lipidation strategy enables albumin binding, reducing plasma clearance and extending circulating half-life to approximately 159–195 hours (~7 days) in pharmacokinetic research studies. Targeted structural modifications (14E/17R salt-bridge substitutions; 25P/28P/29P proline substitutions) simultaneously prevent amyloid fibril formation. Cryo-EM structures published in Nature Communications (2025) resolve AMY-Cg bound to Gs-coupled active AMY1R, AMY2R, AMY3R, and CTR at atomic resolution. Preclinical research in RAMP1/3 knockout mouse models confirms that AMY-Cg's metabolic signalling effects are specifically dependent on intact AMY1R and AMY3R function in hindbrain neuronal circuits (area postrema/NTS). FOR RESEARCH USE ONLY. Not for consumption, human or animal administration, or any application outside a controlled non-clinical laboratory setting.

AMY-Cg/GLP-1-Sm

AMY-Cg/GLP-1-Sm is a co-formulation comprising two distinct peptide analogues: GLP-1-Sm and Cagrilintide. This material is supplied strictly for Research Use Only (RUO) and is not intended for human or veterinary use. It is utilized exclusively in laboratory settings for in vitro and in vivo analysis of metabolic pathways. Profound Aminos makes no therapeutic, diagnostic, or medical claims regarding this compound. The product is provided as a lyophilized powder for solution preparation and analytical characterization.

AOD-9604

AOD-9604 is a synthetic peptide fragment derived from the growth hormone sequence, supplied strictly for laboratory and preclinical investigation. It is used in controlled research environments to explore intracellular metabolic signaling, enzyme interaction pathways, and peptide-driven biochemical modulation. As a highly purified and analytically verified compound, AOD-9604 provides researchers with a reproducible peptide model for studying molecular signaling behavior under in vitro conditions. For Research Use Only (RUO).

Cerebrolysin

Cerebrolysin is a Research Reagent designed strictly for laboratory studies. It features a biological product prepared by enzymatic cleavage of proteins from porcine brain tissue. The resulting hydrolysate contains free amino acids and small neurotrophic peptide fragments, enabling researchers to investigate mechanistic effects on neuronal signaling pathways in controlled laboratory settings. Not intended for human or animal use.

CJC 1295 with DAC 5mg

CJC-1295 with DAC is a long-acting synthetic GHRH analog registered under PubChem CID 91971820. It uses a Drug Affinity Complex to support albumin binding and extended research pharmacokinetics. It is not FDA-approved, and its 2026 U.S. regulatory status remains limited to scientific and compliance reference use.

SKU CJCDAC-5MG-2839

CJC-1295 without DAC

This is a 29-amino acid synthetic GHRH analogue research reagent — formally designated Modified GRF (1-29) and also known as CJC-1295 Without DAC — engineered for laboratory investigation of pulsatile growth hormone axis signalling, hypothalamic-pituitary feedback dynamics, and somatotroph receptor pharmacology. Four targeted amino acid substitutions (D-Ala at position 2, Gln at position 8, Ala at position 15, and Leu at position 27) confer resistance to dipeptidyl peptidase-IV (DPP-IV) enzymatic cleavage, extending functional stability relative to native GHRH while preserving high-affinity GHRH receptor selectivity. Unlike the albumin-conjugated DAC-modified variant, this formulation lacks the Drug Affinity Complex, resulting in a short systemic half-life of approximately 30 minutes — a pharmacokinetic characteristic that makes it the reagent of choice for research models designed to study discrete, physiologically relevant pulsatile GH release patterns. Supplied as lyophilized powder with COA per batch. Not for consumption, parenteral administration, or any application outside a controlled laboratory setting.

CJC-1295/Ipamorelin

CJC-1295 / Ipamorelin is a dual GH secretagogue research combination involving CJC-1295, a GHRH receptor agonist, and Ipamorelin, a GHSR-1a ghrelin receptor agonist. Neither compound is FDA-approved, and no dedicated human clinical trial of the combination has been identified as of June 2026.

Dermorphin

Dermorphin is a naturally occurring opioid heptapeptide derived from Phyllomedusa sauvagei frog skin secretions. Defined by its unique D-Ala² substitution, it exhibits exceptional μ-opioid receptor selectivity and potency in animal models. Dermorphin is not FDA-approved for human or veterinary use, has no recognized clinical pathway in the U.S., and remains a Class I banned substance in equine sport. This resource provides educational and regulatory information for research and professional reference only.

DSIP

DSIP is a high-purity research peptide commonly used to explore slow-wave sleep regulation, neurotransmitter balance, circadian rhythm patterns, and neuroendocrine function. Its biochemical stability and wide physiological influence make it a dependable model for sleep and stress-response studies in controlled laboratory environments.

Epithalon

Epithalon (also known as Epitalon or Ala-Glu-Asp-Gly) is a high-purity research peptide designed for studies involving telomeres, melatonin signaling, oxidative stress, and other aspects of cellular aging. It provides areliable laboratory model for exploring telomerase activation, chromatin structure, and genome stability under controlled conditions.

GHK-CU

GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-complexed tripeptide research reagent supplied as a lyophilized powder for controlled laboratory investigation.Formulated as Glycyl-L-Histidyl-L-Lysine complexed with Cu²⁺, this reagent is extensively characterized in peer-reviewed literature for its role in extracellular matrix signaling, copper coordination chemistry, and multi-pathway cellular biology research. Supplied at 50 analytical mass units with ≥99% purity by RP-HPLC and identity confirmed by LC-MS. Not for consumption, parenteral administration, or any application outside a controlled laboratory setting.

GLOW Protocol

GLOW Peptide (BPC-157 + TB-500 + GHK-Cu) is a high-quality research peptide blend designed to help study how cells heal, grow, and repair tissue. This unique mix includes three well-known peptides BPC-157, TB-500, and GHK-Cu each supporting recovery in its own way. BPC-157 supports cell repair and protection, TB-500 aids tissue flexibility and mobility, while GHK-Cu helps produce new collagen and reduce inflammation. Purified to ≥99% HPLC quality, this blend is reliable for consistent lab results in tissue regeneration and cell health research. ⚠️ Strictly for laboratory research. Not intended for diagnostic, therapeutic, or human use.

GLP-1-Sm

GLP-1-Sm is a long-acting GLP-1 receptor agonist derived from human GLP-1 and engineered for extended activity through DPP-4 resistance and albumin binding. Registered as PubChem CID 56843331 (C187H291N45O59; 4113.58 g/mol), it is the active pharmaceutical ingredient in Ozempic, Wegovy, and Rybelsus. This scientific reference resource provides molecular, pharmacological, and 2026 regulatory overview information for academic and professional use.

GLP-1-Sm/BPC-157

GLP-1-Sm/BPC-157 is a 17 mg dual-component peptide research blend supplied as a lyophilized laboratory material. Listed for research catalogue reference only, with identity, purity, and batch details to be confirmed by Certificate of Analysis.

GLP/GIP-Tz

This is a Research Reagent designed strictly for laboratory Stock Solution Preparation, available in multiple mass formats from 5mg to 120mg. It features a lyophilized “cake” of the Dual-Agonist Ligand (GLP/GIP-Tz), allowing researchers to reconstitute a single, uniform batch for longitudinal metabolic studies at the scale their protocol requires. Higher-mass formats eliminate inter-batch variance found in smaller units when large stock volumes are needed. Not for human use.

GLP/GIP/GLC-Rt

GLP/GIP/GLC-Rt Research Grade (RUO) (CAS 2381089-83-2, LY3437943) is a 39–amino acid unimolecular peptide designed as a triple agonist for GIP / GLP-1 / Glucagon (GCG) receptors. Supplied as a lyophilized white powder with ≥99% purity (HPLC verified) and endotoxin <1.0 EU/mg, it is soluble in Solution. The molecule includes a C20 fatty diacid moiety for albumin binding and extended stability (reported ~6-day half-life), supporting metabolic, obesity, T2D, and hepatic defatting research models.For Research Use Only (RUO). Not for human or veterinary use.

Ipamorelin

Ipamorelin Research Grade (RUO) (CAS 170851-70-4) is a synthetic pentapeptide GHS-R1a (ghrelin receptor) agonist supplied as a lyophilized crystalline powder with ≥99% purity (HPLC verified). Peptide sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (MW 711.868 Da, formula C38H49N9O5). Designed for a GH-selective profile with negligible ACTH/cortisol and prolactin response compared with GHRP-2/6. Soluble in water or sterile saline.COA available (HPLC & MS); cold-chain stored/shipped from the USA.For Research Use Only (RUO). Not for human or veterinary use.

Kisspeptin

Kisspeptin-10 (KP-10) is a synthetic decapeptide research reagent corresponding to the C-terminal active fragment of the KISS1 gene product. Sequence: Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂. It is a potent, well-characterized natural ligand for the KISS1R receptor (GPR54) — a class A Gq-coupled GPCR located at chromosome 19p13.3 (NCBI Gene, updated March 2026). Supplied as a lyophilized powder with ≥99% purity by RP-HPLC, LC-MS identity confirmation, and verified C-terminal amidation. Not for consumption, parenteral administration, or any application outside a controlled laboratory setting.

Klow

This is an 80mg Multi-Pathway Research Reagent designed strictly for laboratory investigation of regenerative signaling pathways. It features a lyophilized blend of four scientifically characterized peptide components ,GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) - each targeting a distinct biological pathway. This formulation enables researchers to investigate simultaneous multi-pathway effects in a single, standardized reagent batch. Not for consumption, parenteral administration, or any application outside a controlled laboratory setting.

LIPO-C

This is a 326mg Multi-Component Lipotropic Research Reagent designed strictly for laboratory investigation of hepatic lipid metabolism, mitochondrial fatty-acid oxidation pathways, and transmethylation biochemistry. It features a lyophilized blend of five scientifically characterized components - L-Carnitine (200mg), L-Methionine (25mg), Myo-Inositol (50mg), Choline Chloride (50mg), and Cyanocobalamin (1mg)  each targeting a distinct metabolic research endpoint. This formulation enables researchers to investigate simultaneous multi-pathway lipotropic effects in a single, standardized reagent batch. Not for consumption, parenteral administration, or any application outside acontrolled laboratory setting.

10ml

Mazdu

Mazdu (Dual-A) is the high-affinity substrate required for isolating metabolic signaling pathways. Unlike mono-ligands (like GLP-1-Sm [Ref Std]), Mazdu (Dual-A) demonstrates simultaneous binding affinity for both the GLP-1 Receptor and the Glucagon Receptor (GCGR), facilitating complex Ex-vivo Research Protocols.

SKU MAZD-6MG-4183

Melanotan 1

Melanotan 1 (MT-1) is a synthetic linear peptide engineered as a potent, MC1R-selective agonist of the melanocortin receptor family. Unlike its cyclic cousin Melanotan 2, Melanotan 1 employs a highly selective binding strategy to target MC1R-the primary receptor controlling skin pigmentation and photoprotection. It is supplied strictly for laboratory investigation into melanogenesis signaling, UV photoprotection mechanisms, and photosensitivity disorder pathophysiology. As a compound with FDA recognition for specific therapeutic applications (EPP) and classified under selective receptor targeting criteria, it remains a cornerstone research tool for understanding melanocortin biology.

Melanotan 2

Melanotan II (MT-II) is a synthetic cyclic heptapeptide engineered to act as a potent, non-selective agonist of the melanocortin peptide receptor family (MC1R, MC3R, MC4R, MC5R). Unlike the linear endogenous hormone $alpha$-MSH, Melanotan II utilizes a lactam bridge cyclization to enhance enzymatic stability and receptor binding affinity. It is supplied strictly for laboratory investigation into melanogenesis signaling, central nervous system (CNS) arousal pathways, and metabolic regulation. Formerly classified in FDA 503A Category 2; removed from that list (effective April 22, 2026) following withdrawal of its nomination. This removal is a procedural step, not an FDA safety clearance — Melanotan II is still awaiting a future FDA Pharmacy Compounding Advisory Committee (PCAC) review (scheduled before end of February 2027) and has not been added to the 503A Bulks List. It is intended solely for controlled in vitro and in vivo animal model research.

MOTS-C

MOTS-c is a mitochondrial-derived research peptide widely used to explore cellular energy balance, glucose control, lipid metabolism, and stress-response pathways. Its stability and mitochondrial origin make it valuable in studies related to metabolic health, aging, and skeletal muscle biology.

NAD+

NAD+ Boosting Compounds combine Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) with specially designed peptide modulators to create a reliable research model for studying cellular energy and mitochondrial function.This formulation supports laboratory research focused on NAD+ biosynthesis, ATP production, and oxidative balance — key pathways behind energy regulation and cellular repair. The combination enhances molecular stability, uptake efficiency, and experimental reproducibility, making it ideal for achieving consistent results in biochemical studies. LYOPHILIZED POWDER - Requires Reconstitution

SKU NAD-500MG-7142

Oxytocin

Oxytocin (PubChem CID 439302; CAS 50-56-6) is a cyclic nonapeptide hormone and neuropeptide involved in reproductive physiology, OXTR receptor signaling, and social-cognition research. It is FDA-approved in the U.S. for specific obstetric uses, while intranasal and non-approved applications remain investigational.

PT-141

PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide melanocortin receptor agonist developed for laboratory investigation of MC1R, MC3R, MC4R, and MC5R receptor signalling pathways. Derived from melanotan II with a cyclic lactam structure and enhanced stability features, it serves as a research tool for studying central melanocortin pharmacology and neural pathway modulation. Supplied as lyophilized powder with COA verification. For laboratory research use only.

Selank

Selank is a high-purity synthetic heptapeptide derived from the natural immunomodulatory molecule tuftsin. It is widely used in molecular neuroscience and psychoneuroimmunology research to investigate GABAergic signaling, serotonin pathways, stress regulation, and immune-neural interactions. Its stability, purity, and predictable activity make it a reliable reagent for academic laboratories and peptide research programs.

Semax

Semax is a high-purity research peptide used in studies related to neuroprotection, synaptic plasticity, oxidative stress, and ischemia-related cellular damage. As an ACTH(4–10) fragment analog, it provides a stable model for investigating BDNF regulation, transcriptomic changes, and neuronal survival pathways.

Sermorelin

Sermorelin Acetate (GHRH 1-29) is a high-purity (≥99%) synthetic peptide for research. Verified CAS 86168-78-7. The primary compliant GHRH agonist for investigating pituitary pulsatility, sleep architecture, and neuroendocrine function. USA Cold-Chain Stored. Research Use Only (RUO).

Snap-8

Acetyl Octapeptide-3 (SNAP-8) is a high-purity synthetic octapeptide reference compound designed for "laboratory-based biochemical and dermatological research. It is structurally derived from the N-terminal region of SNAP-25 and is utilized in laboratory settings to study SNARE-complex interaction pathways (PMC7662462). Documented endpoints in published literature include surface-appearance metrics under controlled in-vitro conditions. This compound is supplied exclusively for use by qualified researchers in institutional laboratory environments. FOR LABORATORY USE ONLY < Not intended for human or animal application.

SS-31

Elamipretide (SS-31, MTP-131) is a mitochondria targeted tetrapeptide with the sequence D-Arg Dmt Lys Phe NH2. In laboratory and preclinical models it binds cardiolipin in the inner mitochondrial membrane, which is associated with stabilized mitochondrial structure, reduced oxidative stress, and improved cellular energy output. Supplied strictly for research use only.

Survo

Survo (BI 456906; CAS 2805997-46-8; PubChem CID 168429725) is a synthetic, acylated 29-amino-acid research peptide derived from the glucagon backbone, engineered as a dual agonist at glucagon receptors (GCGR) and GLP-1 receptors (GLP-1R). A C18 fatty diacid side chain at position 24, linked via a hydrophilic glycine-serine spacer, enables albumin binding for extended circulating presence and once-weekly research protocol administration. A non-coded amino acid (1-aminocyclobutane-1-carboxylic acid; Ac4c) at position 2 differentiates Survo from native glucagon and enhances receptor selectivity. Developed by Boehringer Ingelheim under licence from Zealand Pharma, Survo is in Phase 3 clinical research programmes (SYNCHRONIZE series for body-weight management; LIVERAGE programme for MASH) and holds FDA Breakthrough Therapy Designation for non-cirrhotic MASH with moderate to advanced fibrosis. It is not approved by the FDA for any indication as of March 2026. FOR RESEARCH USE ONLY. Not for consumption, human or animal administration, or any application outside a controlled non-clinical laboratory setting. Researchers require institutional approval, appropriate biosafety protocols, and batch COA documentation before any laboratory use.

TB 500

TB 500 is a high-purity synthetic peptide fragment of Thymosin Beta-4, studied for its impact on cellular migration, actin regulation, and wound-healing pathways. It provides researchers with a reproducible experimental model for investigating tissue regeneration, angiogenesis, and cytoskeletal organization under controlled laboratory conditions.

TB-500/BPC-157 10mg

This research reagent is a Precision Co-Lyophilized Blend of BPC-157 (CAS 137525-51-0) and TB-500 (CAS 885340-08-9). Engineered for advanced regenerative modeling, this "Wolverine" dual-peptide system targets complementary pathways: BPC-157 modulates nitric oxide and VEGF signaling, while TB-500 regulates actin polymerization and cytoskeletal organization.FDA Regulatory Status: FDA Category 2 (Research Use Only). Not for human or animal use, diagnostic, or clinical use.

TB-500/BPC-157 20mg

A high-potency, dual-peptide system combining 10mg BPC-157 and 10mg TB-500 in a single lyophilized vial. Engineered for high-throughput laboratory research requiring elevated concentration gradients. Format: Lyophilized Cake (Stable Powder) Concentration: High (20mg Total) Grade: Research Reagent (>99% Purity)

Tesamorelin

Tesamorelin is a synthetic peptide analogue of the human growth hormone-releasing hormone (GHRH). This material is supplied strictly for Research Use Only (RUO) and is not intended for human or veterinary use. It is utilized exclusively in laboratory settings for in vitro and preclinical experimental models regarding the somatotropic axis and metabolic pathways. Profound Aminos makes no therapeutic, diagnostic, or medical claims regarding this compound. The product is provided as a lyophilized powder for solution preparation and analytical characterization.

TESOFENSINE (Research tablets)

Tesofensine, also known as NS-2330, is a synthetic small-molecule triple monoamine reuptake inhibitor registered under PubChem CID 11370864. It is not a peptide and is distinct from CJC-1295 or ipamorelin. Tesofensine is not FDA-approved as of 2026, while the Tesomet combination remains under regulatory development for specific rare-disease indications.

Thymalin

Thymalin is a heterogeneous thymic polypeptide complex originally isolated from young calf thymus tissue. Unlike single synthetic peptides, it has no single molecular formula or PubChem CID and is composed of multiple bioactive short peptide fractions, including KE dipeptide, EW dipeptide, and EDP. It is distinct from Thymulin, a defined zinc-dependent nonapeptide often confused with Thymalin in the peptide market. In the United States, Thymalin is not FDA-approved and has been specifically cited in FDA enforcement action as an unapproved new drug, making accurate, educational, and non-therapeutic positioning essential.

Thymosin Alpha 1

Thymosin Alpha 1 (Tα1) is a highly purified synthetic thymic peptide used in studies of adaptive immunity, T-cell maturation, cytokine modulation, antiviral signaling, and immune restoration models. In laboratory research, Thymosin Alpha 1 serves as a reliable model compound for examining host defense, interferon pathways, dendritic-cell activation, and immune recovery under controlled experimental conditions.